Indraprastha Medical Corporation Limited (NSE:INDRAMEDCO)
379.80
-3.15 (-0.82%)
May 9, 2025, 3:29 PM IST
NSE:INDRAMEDCO Revenue
Indraprastha Medical Corporation had revenue of 3.25B INR in the quarter ending December 31, 2024, with 6.03% growth. This brings the company's revenue in the last twelve months to 13.37B, up 11.07% year-over-year. In the fiscal year ending March 31, 2024, Indraprastha Medical Corporation had annual revenue of 12.45B with 13.29% growth.
Revenue (ttm)
13.37B
Revenue Growth
+11.07%
P/S Ratio
2.60
Revenue / Employee
4.49M
Employees
2,977
Market Cap
34.75B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 12.45B | 1.46B | 13.29% |
Mar 31, 2023 | 10.99B | 2.11B | 23.70% |
Mar 31, 2022 | 8.88B | 2.75B | 44.80% |
Mar 31, 2021 | 6.13B | -2.17B | -26.17% |
Mar 31, 2020 | 8.31B | 425.96M | 5.40% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 516.03B |
Divi's Laboratories | 90.78B |
Cipla | 267.20B |
Apollo Hospitals Enterprise | 211.46B |
Mankind Pharma | 116.41B |
Zydus Lifesciences | 222.47B |
Aurobindo Pharma | 309.22B |
Alkem Laboratories | 127.57B |